Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CV Sciences ( (CVSI) ) just unveiled an announcement.
On November 21, 2024, CV Sciences, Inc. announced a Stock Purchase Agreement to acquire all shares of Extract Labs, a Colorado corporation, along with shares from Higher Love Wellness Company and Craig Henderson. However, on February 5, 2025, the sellers indicated they could not proceed due to a lack of bank consent, leading to a purported termination of the agreement. CV Sciences disputes this termination and is exploring its options.
More about CV Sciences
CV Sciences, Inc. operates in the pharmaceutical and consumer product industries, focusing on developing and commercializing innovative products based on cannabidiol (CBD) and other hemp-derived compounds.
YTD Price Performance: 29.41%
Average Trading Volume: 262,274
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.07M
For a thorough assessment of CVSI stock, go to TipRanks’ Stock Analysis page.